biotech / news / / The Hindu Business Line
Swiss pharma major Roche on Thursday announced the launch of its atezolizumab injection, Tecentriq SC.
Roche launched Tecentriq SC, a subcutaneous lung cancer treatment, in India for faster administration.
KEY POINTS
- Tecentriq SC can be administered in as little as seven minutes versus hours for IV infusions.
- The new formulation allows treatment in daycare centers, decentralizing cancer care from tertiary hospitals.
- Each Tecentriq SC injection in India is priced at approximately Rs 3.7 lakh.
- Tecentriq SC enables treating up to five patients in the time of one IV infusion.
COMPANIES
Summarized by Newsio from The Hindu Business Line. How we summarize →